A new approach to antiplatelet therapy: Inhibitor of GPIb/V/IX-vWF interaction

Yasuo Ikeda; Makoto Handa; Mitsuru Murata; Shinya Goto

doi:10.1159/000054196

A new approach to antiplatelet therapy: Inhibitor of GPIb/V/IX-vWF interaction

Yasuo Ikeda, Makoto Handa, Mitsuru Murata, Shinya Goto

Department of Transfusion Medicine and Cell Therapy

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Abstract

Evidence has been presented that the interaction between von Willebrand factor (vWF) and its platelet membrane receptor, the GPIb/V/IX complex, plays an important role in the pathogenesis of arterial thrombosis. A monoclonal antibody against the A1 domain of vWF has been shown to inhibit thrombus formation in the animal model of arterial thrombosis. Based upon these findings, a new approach to treating arterial thrombosis has been proposed by intervening in the interaction between vWF and platelet.

Original language	English
Pages (from-to)	44-52
Number of pages	9
Journal	Haemostasis
Volume	30
Issue number	SUPPL. 3
DOIs	https://doi.org/10.1159/000054196
Publication status	Published - 2000

Keywords

Aggregation
Platelet adhesion
Quartz crystal microbalance
Shear stress
von Willebrand factor

ASJC Scopus subject areas

Hematology

Access to Document

10.1159/000054196

Cite this

@article{2a3661b825674a15a7acd2e550c5e24f,

title = "A new approach to antiplatelet therapy: Inhibitor of GPIb/V/IX-vWF interaction",

abstract = "Evidence has been presented that the interaction between von Willebrand factor (vWF) and its platelet membrane receptor, the GPIb/V/IX complex, plays an important role in the pathogenesis of arterial thrombosis. A monoclonal antibody against the A1 domain of vWF has been shown to inhibit thrombus formation in the animal model of arterial thrombosis. Based upon these findings, a new approach to treating arterial thrombosis has been proposed by intervening in the interaction between vWF and platelet.",

keywords = "Aggregation, Platelet adhesion, Quartz crystal microbalance, Shear stress, von Willebrand factor",

author = "Yasuo Ikeda and Makoto Handa and Mitsuru Murata and Shinya Goto",

year = "2000",

doi = "10.1159/000054196",

language = "English",

volume = "30",

pages = "44--52",

journal = "Haemostasis",

issn = "0301-0147",

publisher = "S. Karger AG",

number = "SUPPL. 3",

}

TY - JOUR

T1 - A new approach to antiplatelet therapy

T2 - Inhibitor of GPIb/V/IX-vWF interaction

AU - Ikeda, Yasuo

AU - Handa, Makoto

AU - Murata, Mitsuru

AU - Goto, Shinya

PY - 2000

Y1 - 2000

N2 - Evidence has been presented that the interaction between von Willebrand factor (vWF) and its platelet membrane receptor, the GPIb/V/IX complex, plays an important role in the pathogenesis of arterial thrombosis. A monoclonal antibody against the A1 domain of vWF has been shown to inhibit thrombus formation in the animal model of arterial thrombosis. Based upon these findings, a new approach to treating arterial thrombosis has been proposed by intervening in the interaction between vWF and platelet.

AB - Evidence has been presented that the interaction between von Willebrand factor (vWF) and its platelet membrane receptor, the GPIb/V/IX complex, plays an important role in the pathogenesis of arterial thrombosis. A monoclonal antibody against the A1 domain of vWF has been shown to inhibit thrombus formation in the animal model of arterial thrombosis. Based upon these findings, a new approach to treating arterial thrombosis has been proposed by intervening in the interaction between vWF and platelet.

KW - Aggregation

KW - Platelet adhesion

KW - Quartz crystal microbalance

KW - Shear stress

KW - von Willebrand factor

UR - http://www.scopus.com/inward/record.url?scp=0034488012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034488012&partnerID=8YFLogxK

U2 - 10.1159/000054196

DO - 10.1159/000054196

M3 - Article

C2 - 11182627

AN - SCOPUS:0034488012

VL - 30

SP - 44

EP - 52

JO - Haemostasis

JF - Haemostasis

SN - 0301-0147

IS - SUPPL. 3

ER -

A new approach to antiplatelet therapy: Inhibitor of GPIb/V/IX-vWF interaction

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this